The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men.
Overweight and obesity is one of the risk factors for developing CVD. At present, very little is known about the acute effects of dietary fibre on lipids, glucose and insulin, resting energy expenditure and diet-induced thermogenesis in overweight and obese individuals. This study examined the postprandial metabolic effects of dietary fibre in overweight and obese men. Ten overweight and obese men consumed a mixed meal accompanied by either a high-fibre or low-fibre supplement on two separate visits, in a random order, 1 week apart. Two isoenergetic breakfast meals with similar composition were consumed by ten overweight/obese men. The meals contained either a low (3 g) or high (15 g) amount of fibre, low-fibre meal (LFM) and high-fibre meal (HFM) respectively. Analysis was carried out using paired t test and ANOVA. Serum TAG incremental area under the curve during 6 h of the postprandial period was significantly lower after the consumption of HFM compared with LFM. At the first hour of the postprandial period, plasma apo B48 concentration after consumption of HFM was significantly lower compared with LFM. The resting energy expenditure and diet-induced thermogenesis after both meals was similar during 6 h of the postprandial period. Collectively, these findings suggest that a single acute dose of dietary fibre in the form of psyllium supplement can decrease arterial exposure to TAG and modify chylomicron responses in the postprandial period.
Khossousi
A
A
Department of Nutrition, Dietetics and Food Science, ATN Centre for Metabolic Fitness, School of Public Health, Curtin University, Perth, WA, Australia.
Binns
C W
CW
Dhaliwal
S S
SS
Pal
S
S
D000328:Adult; D000368:Aged; D053283:Apolipoprotein B-48 / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D018592:Cross-Over Studies; D004043:Dietary Fiber / Q000627:therapeutic use*; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D015596:Nutrition Assessment; D009765:Obesity / Q000097:blood / Q000150:complications / Q000503:physiopathology; D050177:Overweight / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D019518:Postprandial Period; D011620:Psyllium / Q000627:therapeutic use*; D022722:Thermogenesis / Q000187:drug effects*; D014280:Triglycerides / Q000097:blood
D053283:Apolipoprotein B-48; D001786:Blood Glucose; D004043:Dietary Fiber; D007328:Insulin; D014280:Triglycerides; D011620:Psyllium